Antithymocyte serum and methotrexate for control of graft-versus-host disease in dogs.
D000818:Animals; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005069:Evaluation Studies as Topic; D006086:Graft vs Host Disease / Q000628:therapy*; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D007106:Immune Sera / Q000008:administration & dosage / Q000009:adverse effects; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011817:Rabbits / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D007106:Immune Sera; D008727:Methotrexate